The oral-respiratory interface: modulation of Streptococcus pneumoniae serotype adhesion by the periodontal pathogen Porphyromonas gingivalis W83 Authors: Chrysanti Murad, Yasmin Hanifa Salma, Imam Megantara, Achadiyani Achadiyani, Ani Melani Maskoen Published: 2026 ABSTRACT ABSTRACTBackgroundPorphyromonas gingivalis, a keystone periodontal pathogen synergizes with Streptococcus pneumoniae by upregulating host receptors like the platelet-activating factor receptor (PAFR). This study investigated whether P. gingivalis W83 differentially modulates the adhesion of four pneumococcal serotypes (3, 4, 6A, and 7F) to alveolar epithelial cells, hypothesizing a strictly serotype-dependent synergy.MethodsAn in vitro model used A549 alveolar epithelial cells conditioned with P. gingivalis W83 supernatant (PgSup) for 24 h. PAFR upregulation was verified via RT-qPCR. Cells were subsequently infected with the specified pneumococcal serotypes. Adhesion was quantified by colony-forming unit (CFU) counts and analyzed via one-way ANOVA.ResultsPgSup significantly upregulated PAFR mRNA expression (p < 0.05). This priming associated with a serotype-dependent enhancement of bacterial adhesion. Serotypes 4 (p = 0.022; 95% CI [3260]–[25273]; Cohen’s d = 2.94) and 7F (p = 0.017; 95% CI [767.6]–[4432]; Cohen’s d = 3.22) demonstrated significant increases in epithelial attachment. Conversely, thickly encapsulated serotypes 3 and 6A exhibited non-significant adhesion increases (p > 0.05).ConclusionP. gingivalis W83 modifies the pulmonary epithelium to favor specific pneumococcal serotypes, an effect temporally associated with host PAFR transcriptional upregulation. These findings highlight a critical oral-respiratory synergy defining host susceptibility to pneumonia.KEYWORDS: A549 cells, bacterial adhesion, platelet activating factor receptor, Porphyromonas gingivalis, Streptococcus pneumoniae Background The oral cavity acts as a primary reservoir for respiratory pathogens, where the aspiration of oral bacteria has been directly implicated in the progression of lower respiratory tract diseases, including pneumonia [1,2]. Periodontitis is a chronic inflammatory disease driven by the dominant pathogen Porphyromonas gingivalis [3–5]. The systemic burden of this chronic inflammation extends far beyond the oral cavity, significantly impacting various systemic conditions. Notably, recent literature highlights the profound impact of periodontitis on cardiovascular disease (CVD) outcomes, emphasizing that supportive periodontal treatments play a crucial role in managing these broader systemic risks [6,7]. In parallel to these well-documented cardiovascular implications, periodontitis is increasingly recognized as a distinct and critical risk factor for respiratory infection. Epidemiological studies demonstrate that individuals with severe periodontal disease face a significantly higher risk of developing and dying from pneumonia [1,8]. This suggests that oral pathogens do not merely coexist with respiratory bacteria but may actively facilitate their colonization [1,8–10]. Streptococcus pneumoniae remains the leading cause of community-acquired pneumonia worldwide, characterized by high rates of hospitalization and mortality [11]. The invasion of the lower respiratory tract relies heavily on bacterial adherence to host receptors; one of the best-characterized is the platelet-activating factor receptor (PAFR), which facilitates pneumococcal adhesion to alveolar epithelial cells [8]. Emerging evidence suggests a synergistic mechanism where P. gingivalis virulence factors “prime” the respiratory tissue by upregulating inflammatory receptors like PAFR, effectively creating a pro-adhesive environment for secondary pneumococcal colonization [1,8–10]. While the general synergy between P. gingivalis and S. pneumoniae is epidemiologically supported, the specificity of this interaction across different pneumococcal strains remains undefined [1,8,10,12]. The rationale of this study is that pneumococcal serotypes possess highly variable capsular structures, which may fundamentally alter their ability to exploit pathogen-modified host environments. Therefore, the specific aim of this study is to investigate whether P. gingivalis W83 differentially modulates the adhesion of four clinically distinct S. pneumoniae serotypes (3, 4, 6A, and 7F) to alveolar epithelial cells. By focusing on serotype-specific responses, this research highlights a novel, nuanced layer of oral-respiratory synergy that may explain variations in host susceptibility to pneumonia. Methods Cell culture The human alveolar epithelial cell line A549 was maintained in Dulbecco’s modified Eagle’s medium (DMEM; Gibco) supplemented with 10% heat-inactivated fetal bovine serum (FBS; Gibco), 100 U mL−1 penicillin and 100 µg mL−1 streptomycin, and cultured at 37°C in a humidified incubator with 5% CO2. A549 cells are widely used as an in vitro model of human alveolar epithelial cells for studies of bacterial adhesion and host–pathogen interactions [8]. The A549 cell line was specifically selected for this study as it provides a standardized, widely validated in vitro model of human alveolar type II pneumocytes, which are the primary targets for pneumococcal adherence in the lower respiratory tract. Bacterial strains Porphyromonas gingivalis strain W83 was cultured anaerobically at 37°C in brain–heart infusion (BHI) broth and agar supplemented with hemin and vitamin K, in accordance with standard protocols for anaerobic periodontal pathogens. Culture supernatants (PgSup) were obtained by centrifugation at 10000 g for 20 min at 4°C. The resulting supernatant was sterilized by filtration through a 0.22 μm pore-size membrane filter, as previously described for bacterial conditioned media used in epithelial cell stimulation studies. Streptococcus pneumoniae serotypes 3, 4, 6A, and 7F used in this study were well-characterized clinical isolates obtained from Microbiology Laboratory, Faculty of Medicine, Universitas Padjadjaran, Indonesia. The isolates were previously serotyped and confirmed via Quellung reaction. The bacteria were grown on 5% sheep blood agar plates at 37°C in 5% CO2 for 18–24 h. Prior to use in adhesion assays, the bacteria were inoculated into brain–heart infusion (BHI) broth and cultured until reaching the mid-logarithmic growth phase, following established pneumococcal culture methods [8,13]. These specific four serotypes were selected to represent a diverse spectrum of capsular phenotypes, allowing for the comparative evaluation of highly mucoid, thickly encapsulated strains (serotypes 3 and 6A) versus strains with thinner capsular profiles known for high invasiveness (serotypes 4 and 7F). RT-qPCR assay A549 cells were seeded in 24-well plates (1 × 105 cells per well) and grown to confluence. Cells were treated with 200 µL PgSup for 24 h at 37°C, while untreated cells served as controls. Total RNA was extracted using the Quick-RNA™ MiniPrep Plus kit according to the manufacturer’s instructions. Quantitative analysis of platelet-activating factor receptor (PAFR) expression was performed using SYBR Green–based one-step RT-qPCR. Relative gene expression was normalized to GAPDH and calculated using the 2− ΔΔCt method [8,14]. Adhesion assay Confluent A549 cells (1 × 105 cells per well) were pre-stimulated with PgSup for 24 h. Cells were then infected with 1 × 107 CFU of S. pneumoniae serotypes 3, 4, 6A, or 7F for 1 h at 37°C. Non-adherent bacteria were removed by washing with sterile PBS. Cells were detached with 0.05% trypsin–EDTA, lysed, and serial dilutions were plated on BHI agar. Adherent bacteria were quantified as colony-forming units (CFUs). This method follows established epithelial adhesion assay protocols for pneumococci [8,15]. Statistical analysis Data were derived from a minimum of three independent experiments and expressed as mean values. Statistical differences were evaluated via one-way ANOVA with Tukey’s post hoc adjustment. Analyses were performed using GraphPad Prism 10, with significance set at p < 0.05 [8]. To quantify the magnitude of the observed effects, 95% confidence intervals (CIs) and effect sizes (Cohen’s d) for pairwise comparisons were calculated and reported alongside the p-values. Results To determine whether P. gingivalis primes the respiratory epithelium for infection, we first evaluated the transcriptional response of A549 alveolar epithelial cells to P. gingivalis W83 culture supernatant (PgSup). The primary target of investigation was the platelet-activating factor receptor (PAFR), a known docking site for pneumococcal invasion. Quantitative analysis via RT-qPCR confirmed that exposure to secreted products from P. gingivalis W83 is sufficient to modulate host gene expression (Figure 1). The modulation of the receptor was statistically significant. A549 cells treated with PgSup for 24 h exhibited a marked upregulation of PAFR mRNA levels compared to the untreated control group (p = 0.0007; 95% CI [2.273] to [4.134]; Cohen’s d = [7.80]). This finding establishes that soluble factors released by P. gingivalis W83 actively alter the surface properties of alveolar epithelial cells, potentially creating a more favorable environment for subsequent bacterial attachment. PAFR transcript levels were quantified by RT-qPCR following 24-h stimulation with P. gingivalis supernatant and normalized to GAPDH. A significant increase in expression was observed in the treated group compared to untreated controls (*p < 0.05). Abbreviations—PAFR: Platelet-Activating Factor Receptor; RT-qPCR: Reverse Transcription-Quantitative Polymerase Chain Reaction; GAPDH: Glyceraldehyde 3-phosphate dehydrogenase; PgSup: P. gingivalis supernatant. Following the confirmation of receptor upregulation, we assessed the functional consequence of this priming using an in vitro adhesion assay. We challenged the PgSup-treated A549 cells with S. pneumoniae serotypes 4 and 7F (Figure 2) and serotypes 3 and 6A (Figure 3). Adherence was subsequently quantified via colony-forming unit (CFU) counts. The data revealed a broad trend where exposure to P. gingivalis supernatant generally increased the number of adherent pneumococci across all tested groups compared to untreated controls. Statistical analysis of the adhesion data revealed a distinct serotype-specific response. The most profound effect was observed in S. pneumoniae serotypes 4 and 7F. The enhanced attachment for serotype 4 was statistically significant (p = 0.022; 95% CI [3260] to [25273]; Cohen’s d = [2.94]), indicating a robust synergistic interaction. Similarly, serotype 7F displayed a significantly elevated adhesion capacity following PgSup treatment (p = 0.017; 95% CI [767.6] to [4432]; Cohen’s d = [3.22]), suggesting that these specific serotypes are particularly responsive to the changes induced by P. gingivalis in the lung epithelium. In contrast to the robust response seen in serotypes 4 and 7F, the remaining serotypes displayed a more muted reaction to the P. gingivalis conditioning. While S. pneumoniae serotype 3 showed an increase in adhesion, the difference did not reach statistical significance (p = 0.146; 95% CI [−2620] to [12220]; Cohen’s d = [1.47]). Likewise, serotype 6A exhibited a modest upward trend in attachment that failed to cross the threshold of significance (p = 0.088; 95% CI [−3945] to [37278]; Cohen’s d = [1.83]). Adhesion of S. pneumoniae serotypes 4 and 7F to P. gingivalis-conditioned A549 cells. CFU enumeration revealed a significant enhancement of bacterial binding for both serotypes (*p < 0.05). Abbreviations—CFU: Colony-Forming Unit; PgSup: P. gingivalis supernatant. Adhesion of S. pneumoniae serotypes 3 and 6A following P. gingivalis priming. CFU analysis indicated no statistically significant difference in attachment levels relative to controls (ns; p > 0.05). Abbreviations—CFU: Colony-Forming Unit; PgSup: P. gingivalis supernatant; ns: not significant. Collectively, these results demonstrate a clear link between P. gingivalis-mediated host modulation and pneumococcal infectivity. The significant upregulation of PAFR (p < 0.05) correlates with a functional increase in bacterial adhesion, but this synergy is not uniform. The data highlights a specific susceptibility profile, where S. pneumoniae serotypes 4 and 7F are significantly more capable of exploiting the P. gingivalis-primed environment than serotypes 3 and 6A. Discussion The present study employed the A549 human alveolar epithelial cell line—a model commonly used to study pneumococcal-host interactions to investigate the mechanistic link between oral pathogens and respiratory infection [8,16–18]. Specifically, our primary results demonstrated that pre-conditioning with P. gingivalis strain W83 secreted product (PgSup) not only significantly upregulated host PAFR mRNA expression but also facilitated a highly serotype-dependent increase in bacterial attachment. We found that this priming environment significantly favored the adhesion of serotypes 4 and 7F, while having no statistically significant impact on the thickly encapsulated serotypes 3 and 6A. These findings align with previous reports indicating that P. gingivalis products can influence host immune pathways to favor bacterial colonization [8,9]. Previous studies have established that supernatants from P. gingivalis elevate PAFR expression and promote pneumococcal adhesion [8,9]. The studies of Kamio et al. reported that P. gingivalis upregulates PAFR expression in alveolar epithelial cells through the proteolytic activity of arginine-specific gingipains (Rgps), whereas other virulence factors like fimbriae or LPS do not trigger this specific receptor modulation [8]. Furthermore, this receptor modulation must be viewed through the lens of biomarker evolution linked with chronic periodontitis. As periodontal disease progresses, the continuous dissemination of oral pathogens and their virulence factors drives a dynamic evolution in the host’s local and systemic inflammatory biomarker profile. The persistent upregulation of cellular biomarkers, such as PAFR, alongside corresponding shifts in pro-inflammatory cytokines, essentially maps the trajectory of host susceptibility. This biomarker evolution transforms the pulmonary epithelium from a baseline state into a highly primed, pro-adhesive niche, thereby continuously lowering the threshold for secondary pneumococcal colonization over time. In this study, we utilized the supernatant of P. gingivalis W83, a virulent encapsulated strain known for its potent proteolytic activity, particularly gingipains (Rgps). Previous studies have established that pneumococcal adhesion to alveolar epithelial cells is enhanced via the upregulation of Platelet-Activating Factor Receptor (PAFR) in an Rgp-dependent manner [8]. Unlike the less virulent, highly fimbriated strain ATCC 33277, strain W83 is associated with a more severe host tissue degradation and systemic dissemination [19]. Therefore, the significant upregulation of PAFR observed in our results likely reflects the high extracellular gingipain activity characteristic of this virulent genotype, underscoring the potential of severe periodontitis to exacerbate respiratory infection risks. However, a limitation of the present study is the lack of direct biochemical characterization of the PgSup. Future investigations utilizing specific gingipain inhibitors or Rgp-deficient mutants are necessary to definitively confirm that the observed PAFR upregulation and subsequent serotype-specific adhesion are exclusively driven by the gingipain activity of the W83 strain. This suggests that the severity of respiratory priming is not uniform across all periodontal infections but may fluctuate based on the specific phenotype of the infecting P. gingivalis strain. Beyond host modulation, we identified a critical serotype-dependent hierarchy in pneumococcal adhesion. Irrespective of P. gingivalis stimulation, serotypes 4 and 7F consistently exhibited higher attachment capacities compared to serotypes 3 and 6A. This observation is consistent with previous studies showing that capsule size and the accessibility of adhesin proteins strongly influence pneumococcal attachment and invasion [18,20–24]. The “capsule shielding” hypothesis posits that thickly encapsulated serotypes often exhibit reduced adhesin exposure. Specifically, established literature characterizes serotype 3 as possessing a uniquely thick, highly mucoid capsular polysaccharide layer, while serotype 6A similarly maintains a robust capsule [25,26]. This physical barrier results in lower epithelial binding but enhanced resistance to immune clearance [21]. In contrast, serotypes 4 and 7F exhibit capsular structures that are relatively thinner or more dynamically regulated during host interaction [26,27]. This anatomical difference allows them to expose more surface adhesins, enabling them to more efficiently exploit host receptors for invasion, consistent with their high clinical association with invasive pneumococcal disease [22–24,26,28]. In direct response to our primary objective, this study demonstrates that P. gingivalis W83 differentially modulates the adhesion of pneumococcal strains to alveolar epithelial cells. We found that the interaction is not universal; rather, P. gingivalis creates a selective niche that significantly favors the adhesion of serotypes 4 and 7F, while showing limited impact on serotypes 3 and 6A. This serotype-specific enhancement, which coincides with the observed upregulation of PAFR, highlights that oral pathogens do not merely facilitate general infection but may actively select for specific, invasive pneumococcal phenotypes. Furthermore, while our initial selection of serotypes 3, 4, 6A, and 7F allowed us to observe the effects of varying capsule thickness on bacterial attachment, this limited panel restricts the overall generalizability of the findings. Future research must expand to include a wider array of highly prevalent and clinically relevant serotypes, such as 1, 14, and 19A, to comprehensively map the clinical scope of this specific oral-respiratory synergy. This study is limited by the absence of direct experimental validation, such as receptor blockade or siRNA-mediated gene silencing, to establish a direct causal link between PAFR expression and bacterial adhesion. Consequently, while our data demonstrate a strong temporal correlation, we cannot definitively conclude that PAFR is the primary or sole mediator of this enhanced adhesion. Other unmeasured host receptors or adhesive factors may also play a significant role. Because post-transcriptional mechanisms can influence final protein abundance, future studies incorporating flow cytometry or Western blot analyses are essential to definitively confirm that this transcriptional upregulation translates to increased functional PAFR protein expression on the epithelial surface. Furthermore, because this study relies exclusively on an in vitro model, it cannot fully replicate the complex immunological and physiological dynamics of an intact respiratory tract. Future in vivo investigations, such as murine co-infection models utilizing P. gingivalis pre-infection followed by pneumococcal challenge, are crucial to validate these specific interactions and determine the overarching clinical impact of this oral-respiratory synergy. Conclusion These findings suggest that P. gingivalis W83 can modulate alveolar epithelial cell responses, creating an environment associated with PAFR upregulation and enhanced pneumococcal adhesion. Notably, this interaction appears serotype-dependent, preferentially favoring the attachment of S. pneumoniae serotypes 4 and 7F compared to serotypes 3 and 6A. While establishing definitive causality for the PAFR mechanism requires further functional validation, this study highlights a potential layer of specificity in oral-respiratory polymicrobial interactions. Recognizing how the biomarker profile of the respiratory epithelium evolves in response to chronic periodontal pathogens underscores the importance of periodontal health in systemic care, suggesting that tracking these biomarker shifts could inform early interventions to mitigate severe pneumonia risks. Acknowledgments Our thanks to the Advanced Biomedical Laboratory, Faculty of Medicine, Universitas Padjadjaran, who assisted in the research. This research has not been previously presented, published, or disseminated in any form or through any platform. Funding Statement Universitas Padjadjaran Institution funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Article highlights Secreted products from the keystone periodontal pathogen Porphyromonas gingivalis strain W83 actively prime the human alveolar epithelium, potentially exacerbating the risk of lower respiratory tract infections. Secreted products from the keystone periodontal pathogen Porphyromonas gingivalis strain W83 actively prime the human alveolar epithelium, potentially exacerbating the risk of lower respiratory tract infections. In vitro exposure to P. gingivalis conditioning significantly upregulates the transcription of Platelet-Activating Factor Receptor (PAFR) messenger RNA (mRNA) in respiratory epithelial cells. In vitro exposure to P. gingivalis conditioning significantly upregulates the transcription of Platelet-Activating Factor Receptor (PAFR) messenger RNA (mRNA) in respiratory epithelial cells. This pathogen-driven host modulation is temporally associated with a highly serotype-dependent enhancement of Streptococcus pneumoniae adhesion to the pulmonary epithelium. This pathogen-driven host modulation is temporally associated with a highly serotype-dependent enhancement of Streptococcus pneumoniae adhesion to the pulmonary epithelium. The primed respiratory environment significantly favors the attachment of highly invasive S. pneumoniae serotypes 4 and 7F, while having no statistically significant impact on thickly encapsulated serotypes 3 and 6A. The primed respiratory environment significantly favors the attachment of highly invasive S. pneumoniae serotypes 4 and 7F, while having no statistically significant impact on thickly encapsulated serotypes 3 and 6A. These findings reveal a novel, selective layer of oral-respiratory polymicrobial synergy, suggesting that chronic periodontitis does not merely facilitate general infection, but may create a tailored niche that dictates host susceptibility to specific pneumococcal strains. These findings reveal a novel, selective layer of oral-respiratory polymicrobial synergy, suggesting that chronic periodontitis does not merely facilitate general infection, but may create a tailored niche that dictates host susceptibility to specific pneumococcal strains. Disclosure statement The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties. The authors used Google Gemini Version 1.5 Pro in order to rewrite and polish the manuscript for improved English language clarity and readability. After using this tool/service, the authors reviewed and edited the content as needed and took full responsibility for the content of the publication. Ethical approval Although this study was exclusively in vitro, the research protocol—including the use of the human-derived A549 cell line and pathogenic bacterial strains—was reviewed and approved by the ethical committee of the Faculty of Medicine, Universitas Padjadjaran No. 434/UN6.KEP/EC/2024 to ensure compliance with institutional biosafety and bioethical standards. Availability of data and material The data supporting the findings of this study are available upon request from the corresponding author, C.M. References Papers of special note have been highlighted as either of interest (•) or of considerable interest (••) to readers. Associated Data Data Availability Statement The data supporting the findings of this study are available upon request from the corresponding author, C.M.